Ads
related to: moderna vaccine- View Meningitis Vaccines
Learn More About Vaccines And
Explore The Meningitis Portfolio
- GSK Meningitis Portfolio
Explore GSK Meningitis Vaccines And
Learn About The Vaccine Portfolio
- Meningitis Portfolio
View Resources & Product Portfolio
Learn About The Vaccine Portfolio
- GSK Portfolio
Learn More About Vaccines And
Explore The Science Behind GSK
- View Meningitis Vaccines
Search results
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 21 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 2 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 15 hours agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 21 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 1,296 shares of the company’s stock in a transaction dated Tuesday, May 28th. Following the ...
The US is close to an agreement on funding for moderna bird flu vaccine trials, the FT reports
Weston Forum· 1 day agoThe Financial Times reported Thursday that the U.S. government is nearing a deal to fund late-stage...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoBeing one of the handful of makers of a COVID-19 vaccine, Moderna reaped the benefits of the...
Thousands to trial personalised cancer vaccines
BBC News· 6 hours agoThousands of NHS cancer patients in England are expected to get access to trials of a new type of treatment using vaccines to fight their disease. Thirty...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 2 days agoThe stock’s drop comes as Moderna awaits important developments involving its experimental cancer...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 5 days agoIts late-stage pipeline is exciting. The company is running phase 3 studies for a combination...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 7 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...